Fisher Funds Management LTD bought a new position in shares of The Allstate Co. (NYSE:ALL – Free Report) during the 4th quarter, HoldingsChannel reports. The institutional investor bought 58,104 shares of the insurance provider’s stock, valued at approximately $11,177,000.
Several other hedge funds have also recently bought and sold shares of ALL. FSA Wealth Management LLC acquired a new stake in shares of Allstate during the third quarter worth about $26,000. Catalyst Capital Advisors LLC purchased a new stake in Allstate during the 3rd quarter worth approximately $29,000. Peoples Bank KS purchased a new stake in Allstate during the 4th quarter worth approximately $49,000. Stonebridge Financial Group LLC acquired a new stake in Allstate during the 4th quarter worth approximately $53,000. Finally, Golden State Wealth Management LLC purchased a new position in Allstate in the 4th quarter valued at approximately $57,000. Institutional investors and hedge funds own 76.47% of the company’s stock.
Insider Activity
In related news, CFO Jesse E. Merten sold 40,102 shares of the stock in a transaction on Monday, February 10th. The shares were sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the completion of the sale, the chief financial officer now owns 18,115 shares in the company, valued at $3,378,990.95. This represents a 68.88 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.80% of the company’s stock.
Allstate Price Performance
Allstate (NYSE:ALL – Get Free Report) last announced its earnings results on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.40 by $2.27. Allstate had a return on equity of 28.20% and a net margin of 7.28%. As a group, sell-side analysts anticipate that The Allstate Co. will post 18.65 EPS for the current year.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on the company. Piper Sandler lifted their target price on Allstate from $206.00 to $244.00 and gave the company an “overweight” rating in a report on Tuesday, November 26th. Barclays decreased their price objective on Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a research note on Monday, January 6th. Morgan Stanley upped their target price on shares of Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a research note on Thursday, November 7th. Evercore ISI raised shares of Allstate from an “in-line” rating to an “outperform” rating in a report on Wednesday, January 8th. Finally, Keefe, Bruyette & Woods boosted their price target on shares of Allstate from $235.00 to $240.00 and gave the stock an “outperform” rating in a report on Tuesday, February 11th. One investment analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, Allstate currently has an average rating of “Moderate Buy” and a consensus target price of $217.94.
View Our Latest Report on Allstate
Allstate Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Read More
- Five stocks we like better than Allstate
- Business Services Stocks Investing
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- DuPont’s Electronics Spinoff: The Start of Something Big
- How to Evaluate a Stock Before Buying
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Want to see what other hedge funds are holding ALL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Allstate Co. (NYSE:ALL – Free Report).
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.